
$324.00
Quality control of anti-Xa chromogenic assays for Rivaroxaban. Learn more about the product and see associated documentation here.
PRODUCT DESCRIPTION
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Lyophilized plasmas, at defined Rivaroxaban concentrations (2 levels of about 15-35 and 45-105 ng/mL), as measured with the BIOPHEN™ DiXal (Ref A221030-RUO) or BIOPHEN™ Heparin LRT (Ref A221011-RUO / A221013-RUO / A221015-RUO), for the quality control of Rivaroxaban measurements using chromogenic assays.
Quality control of anti-Xa chromogenic assays for Rivaroxaban. Learn more about the product and see associated documentation here.
PRODUCT CHARACTERISTICS
Normal human plasma, freeze dried, with Rivaroxaban, at two different concentrations.
High stability following reconstitution.
These controls are calibrated against an Internal Standard for Rixaroxaban, which concentrations have been accurately determined using the reference HPLC method.
PRODUCT COMPONENTS
12 vials of 1 mL of human plasma supplemented at 2 different concentrations of Rivaroxaban (6 vials for each concentration).
PRODUCT APPLICATION
Quality control of anti-Xa chromogenic assays for Rivaroxaban (e.g. BIOPHENâ„¢ DiXal, Ref. A221030-RUO
or BIOPHENâ„¢ Heparin LRT, Ref A221011-RUO / A221013-RUO / A221015-RUO).
MSDS Documents
IFU Documents